Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design-Reference-Cited by-同舟云学术

Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design

Published:2018-10 Issue: Volume:195 Page:28-35
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Jackson Doreen O.,Trappey Francois A.,Clifton G. Travis,Vreeland Timothy J.,Peace Kaitlin M.,Hale Diane F.,Litton Jennifer K.,Murray James L.^ORCID,Perez Sonia A.^ORCID,Papamichail Michael,Mittendorf Elizabeth A.,Peoples George E.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Distribution of HLA antigens;Lee,1990

3. Mittendorf, EA et al. Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients. Annals of Oncology 25, 1735–1742

4. Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis;Andersson;Oncoimmunology,2016

5. Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer;Andersson;Cancer Immunol. Immunother.,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome;International Journal of Molecular Sciences;2023-09-22

2. Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects;Pharmaceuticals;2023-06-25

3. Extracellular Vesicles and Their Current Role in Cancer Immunotherapy;Cancers;2021-05-10

4. Peptide‐based therapeutic cancer vaccine: Current trends in clinical application;Cell Proliferation;2021-03-22

5. Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy;Journal of Cancer;2021